TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29537446

Group type: EXPERIMENTAL
Intervention: Nitrosomonas eutropha (D23)
Number of subjects: 0
Study: 27120004

Group type: EXPERIMENTAL
Intervention: Caffeine consumption (via coffee consumption)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nicotine deprivation (2 hrs)
Number of subjects: 0
Study: 24902628

Group type: EXPERIMENTAL
Intervention: Therapeutic interventions (timed sexual intercourse and assisted reproductive technology)
Number of subjects: 340

Group type: COMPARATOR
Intervention: Infertile couples (undergoing therapeutic interventions)
Number of subjects: 340

Group type: COMPARATOR
Intervention: Couples achieving spontaneous pregnancy
Number of subjects: 340
Study: 23829056

Group type: EXPERIMENTAL
Intervention: Permethrin 2.5% cream (two applications with one week interval)
Number of subjects: 440

Group type: COMPARATOR
Intervention: Tenutex emulsion (single whole-body application)
Number of subjects: 440
Study: 21377341

Group type: EXPERIMENTAL
Intervention: Pressure-controlled ventilation (PCV)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Volume-controlled ventilation (VCV)
Number of subjects: 34
Study: 18192895

Group type: EXPERIMENTAL
Intervention: Aripiprazole (10 mg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 17283867

Group type: EXPERIMENTAL
Intervention: Eccentric dosing of nitrates
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Continuous dosing of nitrates
Number of subjects: 26

Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 26
Study: 12803939

Group type: EXPERIMENTAL
Intervention: Reducing the number of sex partners
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increasing condom use
Number of subjects: 0
Study: 11005946

Group type: EXPERIMENTAL
Intervention: Constant parameter practice
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Variable parameter practice
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: GMP learning
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Force and time parameters manipulation
Number of subjects: 72
Study: 8947616

Group type: EXPERIMENTAL
Intervention: Hypertext access
Number of subjects: 42

Group type: COMPARATOR
Intervention: Boolean access
Number of subjects: 42
Study: 1684481

Group type: EXPERIMENTAL
Intervention: Topical cyclosporin A formulations
Number of subjects: 23
Study: 6793183

Group type: EXPERIMENTAL
Intervention: Cryoprobe
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Morphine infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intramuscular morphine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pain on movement and during physiotherapy
Number of subjects: 0
Study: 31759672

Group type: EXPERIMENTAL
Intervention: Unified Protocol (UP)
Number of subjects: 44
Study: 31327306

Group type: EXPERIMENTAL
Intervention: Intensive Motivational Interviewing (IMI)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Single session of Motivational Interviewing (MI)
Number of subjects: 215
Study: 28402756

Group type: EXPERIMENTAL
Intervention: Instrumented manual therapy plus self‐stretching
Number of subjects: 60

Group type: COMPARATOR
Intervention: Self‐stretching only
Number of subjects: 60
Study: 26311526

Group type: EXPERIMENTAL
Intervention: Reduced dose radiotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard dose post-operative radiotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Post-operative chemoradiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Radiotherapy alone
Number of subjects: 0
Study: 23818718

Group type: EXPERIMENTAL
Intervention: adalimumab + MTX
Number of subjects: 619

Group type: COMPARATOR
Intervention: placebo + MTX
Number of subjects: 619
Study: 21215714

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate for 24 weeks
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo after 2 weeks of prednisone
Number of subjects: 84
Study: 19339957

Group type: EXPERIMENTAL
Intervention: Calcium dobesilate (CD) pretreatment for two weeks before surgery
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no CD pretreatment)
Number of subjects: 30
Study: 17305763

Group type: EXPERIMENTAL
Intervention: Esomeprazole 10 mg once daily for 4 weeks
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg once daily for 4 weeks
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Esomeprazole (both dosages)
Number of subjects: 103
Study: 15142158

Group type: EXPERIMENTAL
Intervention: Stented group (23 patients)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Unstented group (22 patients)
Number of subjects: 45
Study: 11158034

Group type: EXPERIMENTAL
Intervention: Continuous intravenous infusion of recombinant human GHRH-(1-44)-amide
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Estradiol supplementation
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Combined stimulation with GHRH and estradiol
Number of subjects: 9
Study: 9143859

Group type: EXPERIMENTAL
Intervention: Mefloquine
Number of subjects: 1227

Group type: EXPERIMENTAL
Intervention: Proguanil
Number of subjects: 1227

Group type: COMPARATOR
Intervention: Non-users of antimalarials
Number of subjects: 1227
Study: 7515644

Group type: EXPERIMENTAL
Intervention: rhGM-CSF (400 micrograms) subcutaneously days 8-14 of each cycle of intensified COP-BLAM regimen
Number of subjects: 172

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: rhGM-CSF
Number of subjects: 172
Study: 2960473

Group type: EXPERIMENTAL
Intervention: Enoximone (150 mg tid for 6 weeks)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 31389201

Group type: EXPERIMENTAL
Intervention: Trelagliptin 25 mg
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study: 29401258

Group type: EXPERIMENTAL
Intervention: Orthonasal delivery of linalool (12%) at 6 L/min
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Orthonasal delivery of vanillin (25%) at 6 L/min
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Orthonasal delivery of low concentration linalool (1.5%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Orthonasal delivery of low concentration vanillin (6.25%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Retronasal delivery of linalool (12%) at 8 L/min
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Retronasal delivery of vanillin (25%) at 8 L/min
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control study with orthonasal adaptation using matched stimulus concentrations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cross-adaptation assessment between orthonasal and retronasal pathways
Number of subjects: 0
Study: 27450896

Group type: EXPERIMENTAL
Intervention: Suprafascial radial forearm flaps
Number of subjects: 50

Group type: COMPARATOR
Intervention: Subfascial radial forearm flaps
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 50
Study: 25914018

Group type: EXPERIMENTAL
Intervention: Volar locking plates (VLP)
Number of subjects: 111

Group type: COMPARATOR
Intervention: External fixation (EF) with adjuvant pins
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: VLP (C2 subset)
Number of subjects: 111

Group type: COMPARATOR
Intervention: EF (C2 subset)
Number of subjects: 111
Study: 22967437

Group type: EXPERIMENTAL
Intervention: Estrogen treatment
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Testosterone treatment
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 200
Study: 20545955

Group type: EXPERIMENTAL
Intervention: Narrowband ultraviolet B (NB‐UVB)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Psoralen plus ultraviolet A (PUVA)
Number of subjects: 43
Study: 18256431

Group type: EXPERIMENTAL
Intervention: Mass drug administration (MDA) for lymphatic filariasis, administered annually for four years.
Number of subjects: 0
Study: 16109592

Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg/day) for 14 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg/day)
Number of subjects: 40
Study: 12520627

Group type: EXPERIMENTAL
Intervention: Reduced-dose probenecid (RDP) 2 g at 1 hour before cidofovir
Number of subjects: 24

Group type: COMPARATOR
Intervention: Standard-dose probenecid (SDP) 2 g at 3 hours before cidofovir, then 1 g at 2 and 8 hours after cidofovir
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Cidofovir 5 mg/kg as a 1-hour infusion after saline prehydration
Number of subjects: 24
Study: 10799813

Group type: EXPERIMENTAL
Intervention: Paracetamol tablet with sodium bicarbonate (630 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Paracetamol tablet with sodium bicarbonate (400 mg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Paracetamol tablet with calcium carbonate (375 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional paracetamol tablet (500 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Soluble paracetamol tablet
Number of subjects: 0
Study: 8780277

Group type: EXPERIMENTAL
Intervention: Spinal anesthesia with 25 micrograms fentanyl (FN)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Spinal anesthesia with 12.5 mg bupivacaine plus saline (SS)
Number of subjects: 40
Study: 1610577

Group type: EXPERIMENTAL
Intervention: Midazolam 2 mg IV
Number of subjects: 139

Group type: COMPARATOR
Intervention: Placebo (saline 2 ml IV)
Number of subjects: 139
Study: 6386936

Group type: EXPERIMENTAL
Intervention: Intranasal fenoterol (0.2 mg in each nostril, total 0.8 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Oral fenoterol (0.4 mg inhalation)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Intranasal fenoterol
Number of subjects: 10
Study: 31837238

Group type: EXPERIMENTAL
Intervention: Ordinal outcomes based on baseline platelet count (cutoff, 150 × 10^9/L)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Ordinal outcomes in a hypothetical study to prevent decompensation
Number of subjects: 202
Study: 30638768

Group type: EXPERIMENTAL
Intervention: Niraparib (300 mg once daily)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 28683357

Group type: EXPERIMENTAL
Intervention: Concurrent training (16-week, 3 times per week of heart rate guided-aerobic plus resistance training)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (recreational activities)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Concurrent training
Number of subjects: 49
Study: 25555415

Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Paroxetine and Bupropion
Number of subjects: 0
Study: 24021733

Group type: EXPERIMENTAL
Intervention: Behavioral Nutrition Intervention for Community Elders (B-NICE)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 34
Study: 21436683

Group type: EXPERIMENTAL
Intervention: Morphine and ketamine (MK)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Morphine and saline (MS)
Number of subjects: 11
Study: 19766399

Group type: EXPERIMENTAL
Intervention: Silicone gel (Scarfade)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Silicone gel sheet (Epi-Derm)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Topical onion extract including heparin and allantoin (Contractubex)
Number of subjects: 45
Study: 16463192

Group type: EXPERIMENTAL
Intervention: McPeek score
Number of subjects: 669
Study: 12643601

Group type: EXPERIMENTAL
Intervention: Survivin mRNA and protein expression in gastric cancer and surrounding gastric mucosa
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Caspase-3 expression in gastric cancer
Number of subjects: 30

Group type: COMPARATOR
Intervention: Caspase-3 expression in normal subjects
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Caspase-3 expression in surrounding gastric mucosa
Number of subjects: 30
Study: 11429022

Group type: EXPERIMENTAL
Intervention: Preemptive ganciclovir treatment for asymptomatic infection
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Managed according to the program
Number of subjects: 90

Group type: COMPARATOR
Intervention: Non-compliance with the program
Number of subjects: 90
Study: 8793575

Group type: EXPERIMENTAL
Intervention: Dopamine (5 micrograms/kg/min) infused starting 30 min before cardiac catheterization and continued for 6 h thereafter
Number of subjects: 40
Study: 1616257

Group type: EXPERIMENTAL
Intervention: Palpation of Dorsalis Pedis (DP) pulse
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Palpation of Posterior Tibial (PT) pulse
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Doppler assessment of PT artery
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Doppler assessment of DP artery
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Pressure measurements by observers
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (no disagreement in DP pulses)
Number of subjects: 38
Study: 6203304

Group type: EXPERIMENTAL
Intervention: Clobetasol propionate and UVB
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo/UVB
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clobetasol propionate alone
Number of subjects: 0
Study: 31028444

Group type: EXPERIMENTAL
Intervention: Structured reports by English-speaking radiologists (translated into German)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: German structured reports by German radiologists
Number of subjects: 2

Group type: COMPARATOR
Intervention: Free-text reports by German radiologists
Number of subjects: 2
Study: 29513088

Group type: EXPERIMENTAL
Intervention: Coffee polyphenols (CPPs)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 10
Study: 26733582

Group type: COMPARATOR
Intervention: Sinus Rhythm at baseline and discharge (SR/SR)
Number of subjects: 1879

Group type: EXPERIMENTAL
Intervention: Sinus Rhythm at baseline and Atrial Fibrillation at discharge (SR/AF)
Number of subjects: 1879

Group type: EXPERIMENTAL
Intervention: Atrial Fibrillation at baseline and discharge (AF/AF)
Number of subjects: 1879

Group type: EXPERIMENTAL
Intervention: Atrial Fibrillation at discharge with lower ventricular response (<90 bpm)
Number of subjects: 1879
Study: 24498368

Group type: EXPERIMENTAL
Intervention: Nordic FLOX (oxaliplatin and 5-fluorouracil)
Number of subjects: 566

Group type: EXPERIMENTAL
Intervention: Nordic FLOX + cetuximab
Number of subjects: 566

Group type: EXPERIMENTAL
Intervention: Nordic FLOX + cetuximab for 16 weeks followed by cetuximab alone as maintenance therapy
Number of subjects: 566

Group type: EXPERIMENTAL
Intervention: Updated plasma YKL‐40 levels after treatment
Number of subjects: 566
Study: 21347595

Group type: EXPERIMENTAL
Intervention: Zero calcium score criteria
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Patients with ≥50% CAD without detectable CAC
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Patients diagnosed with ACS
Number of subjects: 136
Study: 20739874

Group type: EXPERIMENTAL
Intervention: Marine collagen peptides (MCPs) treatment
Number of subjects: 100

Group type: COMPARATOR
Intervention: Patient control (carboxymethylcellulose)
Number of subjects: 100
Study: 17665470

Group type: EXPERIMENTAL
Intervention: Manual therapy and directed exercise
Number of subjects: 156

Group type: COMPARATOR
Intervention: Placebo (sham ultrasound)
Number of subjects: 156
Study: 16099892

Group type: EXPERIMENTAL
Intervention: RAP+CrCP model during mental activation tasks
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: CVR model during mental activation tasks
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: RAP model during mental activation tasks
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: CrCP model during mental activation tasks
Number of subjects: 13
Study: 12098158

Group type: COMPARATOR
Intervention: Control subjects (men and women)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control men
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control women
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Men with Parkinson's disease
Number of subjects: 40
Study: 10196463

Group type: EXPERIMENTAL
Intervention: Impaired phosphorylation of cyclic AMP response element binding protein (pCREB) in DAT
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (non-DAT)
Number of subjects: 0
Study: 7495918

Group type: EXPERIMENTAL
Intervention: Exploration phase with rewards based on right minus left alpha differences exceeding baseline mean plus 0.85 SD (p = 0.20)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Training phase with rewards based on hit rates
Number of subjects: 13
Study: 2405531

Group type: EXPERIMENTAL
Intervention: 145 cGy n gamma x twelve fractions, three fractions per week (total 17.4 Gy n gamma)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: 155 cGy n gamma x twelve fractions, three fractions per week (total 18.6 Gy n gamma)
Number of subjects: 28
Study: 7009441

Group type: EXPERIMENTAL
Intervention: Carprofen stepwise 150, 200, and 250 mg/day
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Carprofen 350, 400, and 450 mg/day
Number of subjects: 36

Group type: COMPARATOR
Intervention: Indomethacin 100 mg/day
Number of subjects: 36

Group type: COMPARATOR
Intervention: Carprofen low dosage regimen
Number of subjects: 36
Study: 31196016

Group type: EXPERIMENTAL
Intervention: Carglumic acid (50 mg/kg/day) plus standard therapy (protein-restricted diet, L-carnitine, and metronidazole)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard therapy alone (protein-restricted diet, L-carnitine, and metronidazole)
Number of subjects: 0
Study: 28926579

Group type: COMPARATOR
Intervention: LBC screening
Number of subjects: 4995

Group type: EXPERIMENTAL
Intervention: HPV+LBC triage
Number of subjects: 4995

Group type: EXPERIMENTAL
Intervention: HPV+DS triage
Number of subjects: 4995
Study: 25550147

Group type: EXPERIMENTAL
Intervention: Anodal tDCS (1 mA, 10 + 10') with 10 min interval
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Anodal tDCS (1 mA, 10 + 10') with 30 min interval
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Anodal tDCS (1 mA, 10 + 10') with 60 min interval
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS with 10 min interval
Number of subjects: 15
Study: 23452586

Group type: EXPERIMENTAL
Intervention: Iron- and zinc-fortified infant cereals
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Iron-only fortified infant cereals
Number of subjects: 45

Group type: COMPARATOR
Intervention: Commercially available pureed meats
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Enteric microbiota in the meat FG
Number of subjects: 45
Study: 21071558

Group type: EXPERIMENTAL
Intervention: EPO therapy (50 IU/kg/wk) for 52 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: No EPO therapy (control group)
Number of subjects: 0
Study: 18536953

Group type: EXPERIMENTAL
Intervention: Alendronate 280 mg once-weekly oral buffered solution (OW OBS)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Alendronate 40 mg/day tablet
Number of subjects: 63
Study: 16622266

Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy (CDDP)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Radiotherapy
Number of subjects: 115
Study: 11797178

Group type: EXPERIMENTAL
Intervention: Nevirapine (group A)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Efavirenz (group B)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Protease Inhibitor (group C)
Number of subjects: 77
Study: 11104404

Group type: EXPERIMENTAL
Intervention: Secretin infusion
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 20
Study: 8643963

Group type: EXPERIMENTAL
Intervention: Paclitaxel and carboplatin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Paclitaxel/cisplatin
Number of subjects: 0
Study: 2090619

Group type: EXPERIMENTAL
Intervention: Family therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Methadone treatment
Number of subjects: 0
Study: 6256579

Group type: EXPERIMENTAL
Intervention: Topical steroids
Number of subjects: 53

Group type: COMPARATOR
Intervention: Artificial tears
Number of subjects: 53
Study: 30354751

Group type: EXPERIMENTAL
Intervention: Refractory Hypertension (RfH)
Number of subjects: 229

Group type: COMPARATOR
Intervention: Resistant Hypertension (RH)
Number of subjects: 229
Study: 28490349

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT) intervention consisting of one 60-minute session and seven 30-minute telephone/Skype sessions over an eight-week period.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fatigue information sheet to use without therapist help (Control group).
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT) intervention
Number of subjects: 0
Study: 26265979

Group type: EXPERIMENTAL
Intervention: Insured patients requesting appointments
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Uninsured patients able to pay upfront (>$100) requesting appointments
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Uninsured patients requesting appointments
Number of subjects: 380

Group type: COMPARATOR
Intervention: Patients requesting appointments from clinics located farther than 30 miles from an ED
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: Patients requesting appointments from clinics located within 30 miles of an UC
Number of subjects: 380
Study: 23698243

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided injection (0.5 mL dexamethasone suspension and 3 mL lidocaine)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Palpation-guided injection (0.5 mL dexamethasone suspension and 3 mL lidocaine)
Number of subjects: 92
Study: 21347765

Group type: EXPERIMENTAL
Intervention: TigerKids program
Number of subjects: 2658
Study: 19052293

Group type: EXPERIMENTAL
Intervention: ivermectin (ivc)
Number of subjects: 834

Group type: EXPERIMENTAL
Intervention: albendazole (alb)
Number of subjects: 834

Group type: EXPERIMENTAL
Intervention: combination (comb)
Number of subjects: 834

Group type: COMPARATOR
Intervention: reference group (ref)
Number of subjects: 834
Study: 16603345

Group type: EXPERIMENTAL
Intervention: MALDI-TOF serum protein profiling
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 116
Study: 14964327

Group type: EXPERIMENTAL
Intervention: Sound field FM amplification (SFA) in treatment group classrooms
Number of subjects: 14

Group type: COMPARATOR
Intervention: No sound field FM amplification in control group classrooms
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Sound field FM amplification (SFA)
Number of subjects: 14

Group type: COMPARATOR
Intervention: No sound field FM amplification
Number of subjects: 14